FREE Webinar
Tuesday, May 12, 2020
2:30 - 4:00 PM, Eastern Standard Time
Cancer vaccines target unique antigens on tumors, including overexpressed healthy proteins or virus-derived proteins. Each individual tumor is unique, carrying its own distinguishing antigens, which can complicate the cancer vaccine development process. To better characterize, identify, and understand the dynamic interactions between the immune system and cancer cell antigens, researchers can turn to advanced flow cytometry and live-cell imaging technologies. This webinar, brought to you by The Scientist and sponsored by Sartorius, will present new research and developments in the cancer vaccine field, and delve into the intricacies of target discovery and vaccine development.
Topics to be covered
Meet the Speakers:
David E. Avigan, MD
Professor of Medicine
Beth Israel Deaconess Medical Center
Mary L. (Nora) Disis, MDHelen B. Slonaker Endowed Professor for Cancer ResearchAmerican Cancer Society Clinical Research ProfessorProfessor, Medicine, Adjunct Professor ...
